Regenerative medicine for spinal cord injury at subacute stage using human induced pluripotent stem cell-derived neural stem/progenitor cells

General Information

Clinical trials phase Not applicable
Start date (estimated) 2021-12-07
Clinical feature
Label Spinal cord injury

Administrative Information

ICTRP weblink
Other study identifiers
Name UMIN000035074
Description UMIN Clinical Trials Registry (UMIN-CTR)
Name jRCTa031190228
Description Japan Registry of Clinical Trials (jRCT)
Source weblink
Public contact
Public email
First name Masaya
Last name Masaya
Phone +81 3-3353-1211
City Tokyo
Address freetext 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582 Japan
Sponsors Keio University


Which differentiated cell type is used
Label neural stem cell
Description An undifferentiated neural cell that originates from the neuroectoderm and has the capacity both to perpetually self-renew without differentiating and to generate multiple central nervous system neuronal and glial cell types.


Recruitment Status Recruiting
Estimated number of participants 4